Your browser doesn't support javascript.
loading
Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis.
Palencia, Andrés; Bougdour, Alexandre; Brenier-Pinchart, Marie-Pierre; Touquet, Bastien; Bertini, Rose-Laurence; Sensi, Cristina; Gay, Gabrielle; Vollaire, Julien; Josserand, Véronique; Easom, Eric; Freund, Yvonne R; Pelloux, Hervé; Rosenthal, Philip J; Cusack, Stephen; Hakimi, Mohamed-Ali.
Afiliação
  • Palencia A; Institute for Advanced Biosciences (IAB), Team Host-Pathogen Interactions & Immunity to Infection, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France andres.palencia@univ-grenoble-alpes.fr alexandre.bougdour@univ-grenoble-alpes.fr mohamed-ali.hakimi@univ-grenoble-alpes.fr.
  • Bougdour A; European Molecular Biology Laboratory (EMBL), Grenoble Outstation and Unit of Virus Host-Cell Interactions, University of Grenoble-EMBL-Centre National de la Recherche Scientifique, Grenoble Cedex 9, France.
  • Brenier-Pinchart MP; Institute for Advanced Biosciences (IAB), Team Host-Pathogen Interactions & Immunity to Infection, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France andres.palencia@univ-grenoble-alpes.fr alexandre.bougdour@univ-grenoble-alpes.fr mohamed-ali.hakimi@univ-grenoble-alpes.fr.
  • Touquet B; Institute for Advanced Biosciences (IAB), Team Host-Pathogen Interactions & Immunity to Infection, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
  • Bertini RL; Institute for Advanced Biosciences (IAB), Team Host-Pathogen Interactions & Immunity to Infection, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
  • Sensi C; Institute for Advanced Biosciences (IAB), Team Host-Pathogen Interactions & Immunity to Infection, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
  • Gay G; European Molecular Biology Laboratory (EMBL), Grenoble Outstation and Unit of Virus Host-Cell Interactions, University of Grenoble-EMBL-Centre National de la Recherche Scientifique, Grenoble Cedex 9, France.
  • Vollaire J; Institute for Advanced Biosciences (IAB), Team Host-Pathogen Interactions & Immunity to Infection, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
  • Josserand V; Institute for Advanced Biosciences (IAB), OPTIMAL Small Animal Imaging Facility, Grenoble, France.
  • Easom E; Institute for Advanced Biosciences (IAB), OPTIMAL Small Animal Imaging Facility, Grenoble, France.
  • Freund YR; Anacor Pharmaceuticals Inc., Palo Alto, CA, USA.
  • Pelloux H; Anacor Pharmaceuticals Inc., Palo Alto, CA, USA.
  • Rosenthal PJ; Institute for Advanced Biosciences (IAB), Team Host-Pathogen Interactions & Immunity to Infection, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
  • Cusack S; Department of Medicine, University of California, San Francisco, CA, USA.
  • Hakimi MA; European Molecular Biology Laboratory (EMBL), Grenoble Outstation and Unit of Virus Host-Cell Interactions, University of Grenoble-EMBL-Centre National de la Recherche Scientifique, Grenoble Cedex 9, France.
EMBO Mol Med ; 9(3): 385-394, 2017 03.
Article em En | MEDLINE | ID: mdl-28148555
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Toxoplasma / Compostos de Boro / Toxoplasmose / Fator de Especificidade de Clivagem e Poliadenilação / Antiprotozoários Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Toxoplasma / Compostos de Boro / Toxoplasmose / Fator de Especificidade de Clivagem e Poliadenilação / Antiprotozoários Idioma: En Ano de publicação: 2017 Tipo de documento: Article